I now have all the information needed to write comprehensive, exam-quality answers. Let me compose the full answers.
MICROBIOLOGY - PAPER I (RS-4 & RS-5)
Long Essay Answers (10 Marks Each)
QUESTION 1 — Visceral Leishmaniasis (Kala-azar)
Clinical Diagnosis: The bone marrow aspirate showing amastigotes filled within a macrophage on Giemsa stain is pathognomonic. This is Visceral Leishmaniasis (Kala-azar).
a) Etiological Agent and Clinical Diagnosis
| Feature | Details |
|---|
| Etiological Agent | Leishmania donovani |
| Clinical Diagnosis | Visceral Leishmaniasis (Kala-azar / "Dum-dum fever" / "Black fever") |
| Vector | Female Phlebotomus sandfly |
| Reservoir | Rodents, dogs, wild canids (humans also act as reservoir in India) |
Morphological forms:
- Amastigote (Leishman-Donovan body / LD body): Oval, 2-3 μm, intracellular form found inside macrophages; has a nucleus and a rod-like kinetoplast appearing as a "dot and dash" on Giemsa stain
- Promastigote: Elongated, flagellated, found in sandfly gut and culture media
Histopathology image - L. donovani amastigotes (arrows) from a liver biopsy:
(Arrows point to amastigotes [LD bodies] within macrophage cytoplasm - Medical Microbiology, Jawetz 28e)
b) Life Cycle and Pathogenesis of Leishmania donovani
Life Cycle Flowchart:
SANDFLY (Phlebotomus) — Female sandfly bites infected host
│
▼
Ingests amastigotes from blood/macrophages
│
▼
SANDFLY MIDGUT: Amastigotes transform into → PROMASTIGOTES (flagellated)
│
▼
Promastigotes multiply by binary fission, migrate to proboscis
│
▼
Sandfly bites new host — injects PROMASTIGOTES into skin
│
▼
HUMAN HOST: Promastigotes phagocytosed by neutrophils/macrophages
│
▼
Inside phagolysosome: Promastigotes → transform to AMASTIGOTES
│
▼
Amastigotes multiply within macrophages (resist lysosomal killing)
│
▼
Infected macrophages burst → amastigotes released
│
▼
Taken up by other macrophages → spread via lymphatics/bloodstream
│
▼
Reticuloendothelial system (RES): Spleen, Liver (Kupffer cells),
Bone marrow, Lymph nodes → massive colonization
│
▼
KALA-AZAR: Hepatosplenomegaly, Pancytopenia, Fever, Weight loss
Pathogenesis:
- Entry: Promastigotes injected by sandfly are phagocytosed by skin macrophages
- Intracellular survival: L. donovani inhibits phagolysosome fusion and resists oxidative killing - the parasite lives and multiplies as amastigotes in macrophage cytoplasm
- Dissemination: Infected macrophages carry the parasite via lymphatics to the liver, spleen, bone marrow, and lymph nodes (RES organs)
- Hyperplasia of spleen: Marked splenomegaly due to RES proliferation
- Bone marrow suppression: Amastigotes fill bone marrow macrophages → pancytopenia (anaemia, leukopenia, thrombocytopenia)
- Immune dysregulation: Defective cell-mediated immunity (CMI), polyclonal B-cell activation → hypergammaglobulinemia
- Fever: Irregular, hectic fever due to cytokine release (IL-1, TNF)
- Post-kala-azar dermal leishmaniasis (PKDL): Occurs 1-2 years after treatment in Indian kala-azar - cutaneous vesicles with abundant parasites
Clinical Features Summary:
- Prolonged irregular fever (>2 weeks)
- Progressive weight loss and cachexia
- Massive splenomegaly (most prominent sign) + hepatomegaly
- Pancytopenia → anaemia, bleeding tendency, susceptibility to infections
- Hyperpigmentation of skin (hence "Kala-azar" = black fever in Hindi)
- Hypoalbuminemia and hypergammaglobulinemia
c) Laboratory Diagnosis of Visceral Leishmaniasis
Flowchart - Laboratory Diagnosis:
SUSPECTED KALA-AZAR
│
┌────┴────────────────────────────────────┐
│ │
PARASITOLOGICAL SEROLOGICAL /
METHODS IMMUNOLOGICAL
│ │
├─ Bone Marrow Aspirate (GOLD ├─ rK39 ICT strip test
│ STANDARD): Giemsa stain │ (Rapid, field diagnosis)
│ → LD bodies in macrophages │
│ ├─ DAT (Direct Agglutination Test)
├─ Splenic Aspirate: │
│ Most sensitive (>95%) ├─ ELISA (anti-Leishmania Ab)
│ but risk of bleeding │
│ ├─ CFT (Complement Fixation Test)
├─ Liver Biopsy: │ - Chopra's aldehyde test
│ Less sensitive than spleen │ (turbidity in hypergammaglobu-
│ │ linaemia - non-specific)
├─ Lymph node aspirate │
│ └─ Leishmanin (Montenegro)
├─ Peripheral blood smear (buffy coat) skin test: NEGATIVE in
│ - less sensitive active disease (CMI depressed)
│
├─ NNN CULTURE MEDIUM: Promastigotes
│ visible in 1-4 weeks
│
└─ PCR: Sensitive and specific,
detects Leishmania DNA in blood/
tissue. Used for species ID
│
MOLECULAR
METHODS
│
└─ PCR on blood, bone marrow, or
splenic aspirate
Supporting Hematological Findings:
| Parameter | Finding |
|---|
| Hemoglobin | Low (normocytic normochromic anaemia) |
| WBC | Leukopenia |
| Platelets | Thrombocytopenia |
| ESR | Elevated |
| Serum proteins | Low albumin; High globulin (IgG) |
| Formol-gel (Napier's) test | Positive (due to hyperglobulinaemia - white precipitate with formalin) |
Sources: Medical Microbiology 9e (Murray); Jawetz Melnick & Adelberg's Medical Microbiology 28e
QUESTION 2 — Bacillary Dysentery (Shigellosis)
Clinical Diagnosis: A 25-year-old with fever, tenesmus, blood/mucus in stools, pus cells on microscopy, no ova/cysts, and non-lactose fermenting colonies on stool culture = Bacillary Dysentery caused by Shigella spp.
a) Etiological Agent
| Feature | Details |
|---|
| Organism | Shigella species |
| Common species | S. flexneri (developing countries - most common), S. sonnei (developed countries), S. dysenteriae (most severe), S. boydii |
| Morphology | Gram-negative, non-motile, non-capsulated rod; facultative anaerobe |
| Biochemistry | Non-lactose fermenter (key clue in case!), oxidase-negative |
| Antigens | O (somatic) antigen used for serogroup classification |
| Minimum infective dose | As few as 10-100 organisms (very low infectious dose) |
b) Pathogenesis and Complications
Pathogenesis Flowchart:
INGESTION of ≥10-100 Shigella organisms (fecal-oral route)
│
▼
Reach SMALL INTESTINE → Initial colonization
│
▼
Produce ENTEROTOXIN → early WATERY DIARRHEA
(first 12-24 hours)
│
▼
Bacteria reach COLON (large intestine)
│
▼
Invade M-cells (Microfold cells) overlying Peyer's patches
via TYPE III SECRETION SYSTEM (T3SS)
│
▼
T3SS injects IpaA, IpaB, IpaC, IpaD proteins into epithelial cells
│
▼
Membrane RUFFLING → Macropinocytosis → Bacterial engulfment
│
▼
Shigella LYSE the phagosome → escape into CYTOPLASM
(unlike Salmonella which stays in vacuole)
│
▼
ACTIN POLYMERIZATION propels bacteria cell-to-cell
(protected from immune clearance)
│
▼
Induce APOPTOSIS of macrophages → release IL-1β
│
▼
IL-1β attracts NEUTROPHILS (PMNs) → mucosal inflammation
(pus cells in stool!)
│
▼
Disruption of INTESTINAL WALL INTEGRITY
│
▼
BLOODY DYSENTERY: Blood, mucus, pus in stool
Severe cramps + Tenesmus (painful urge to defecate)
│
▼
S. dysenteriae: SHIGA TOXIN (AB5 toxin)
B subunits → bind Gb3 receptor on endothelial cells
A subunit → cleaves 28S rRNA → BLOCKS PROTEIN SYNTHESIS
│
▼
Intestinal epithelial damage + (in small subset) Glomerular
endothelial damage → HEMOLYTIC UREMIC SYNDROME (HUS)
Shiga Toxin Mechanism:
- Structure: 1 A subunit + 5 B subunits (AB5 toxin)
- Receptor: B subunits bind glycolipid Gb3 on host cells
- Action: A subunit cleaves 28S rRNA of 60S ribosomal subunit → blocks aminoacyl-tRNA binding → inhibits protein synthesis → cell death
Complications:
| Complication | Details |
|---|
| HUS | Hemolytic uremic syndrome - S. dysenteriae Shiga toxin; triad: microangiopathic hemolytic anemia + thrombocytopenia + renal failure |
| Reactive arthritis (Reiter syndrome) | Weeks after infection; HLA-B27 association |
| Septicemia | Rare, mainly in malnourished children |
| Toxic megacolon | Especially S. dysenteriae |
| Pseudomembranous colitis | |
| Intestinal perforation | Severe cases |
| Seizures/Encephalopathy | Ekiri syndrome (especially in children) |
| Nutritional deficiency | Protein-losing enteropathy |
c) Laboratory Diagnosis
Flowchart - Laboratory Diagnosis of Shigellosis:
CLINICAL SUSPICION (fever + tenesmus + bloody-mucoid stools)
│
┌─────────┴────────────────────────┐
│ │
MICROSCOPY CULTURE
(Immediate) (Definitive)
│ │
├─ Stool wet mount: Collect FRESH stool
│ • Abundant pus cells (PMNs) │
│ • RBCs ├─ MacConkey agar:
│ • Mucus │ PALE/COLORLESS colonies
│ • NO cysts/ova │ (non-lactose fermenter)
│ (distinguishes from │
│ parasitic dysentery) ├─ XLD (Xylose Lysine
│ │ Deoxycholate) agar:
├─ Giemsa stain (PMNs, │ Pink/red colonies
│ intracellular bacteria │ (no H2S - no black center)
│ in severe cases) │
│ ├─ Hektoen Enteric (HE) agar:
│ │ Green colonies
│ │
│ ├─ Selenite F broth: enrichment
│ │
│ └─ BIOCHEMICAL ID:
│ • Glucose fermented (acid, no gas)
│ • Lactose: NOT fermented
│ • H2S: Negative
│ • Urease: Negative
│ • Motility: Non-motile
│
SEROLOGY MOLECULAR
│ │
├─ Widal-type slide └─ Multiplex PCR / NAATs
│ agglutination with (GOLD STANDARD - enteric
│ Shigella antisera multiplex panels)
│ (confirm O-antigen Detects virulence genes
│ group A/B/C/D) (ipaH, Shiga toxin genes)
│
└─ Not routinely done
(culture preferred)
Culture Characteristics on MacConkey Agar:
| Organism | MacConkey Agar |
|---|
| E. coli | Pink (lactose fermenter) |
| Shigella | Pale/Colorless (non-lactose fermenter) |
| Salmonella | Pale (non-lactose fermenter) |
| Klebsiella | Pink, mucoid |
Additional Identification Steps:
- Serotyping: Slide agglutination with polyvalent antisera (Groups A, B, C, D)
- Group A = S. dysenteriae (12 serotypes)
- Group B = S. flexneri (6 serotypes)
- Group C = S. boydii (18 serotypes)
- Group D = S. sonnei (1 serotype)
-
Antibiotic Sensitivity Testing: Required due to multidrug resistance; fluoroquinolones or azithromycin are standard empirical therapy
-
NAATs / Multiplex PCR: Now considered the gold standard for diagnosis - detects ipaH gene (invasion plasmid) and Shiga toxin genes
Sources: Medical Microbiology 9e (Murray/Rosenthal); Red Book 2021; Rosen's Emergency Medicine
Quick Summary Table:
| Feature | Q1: Kala-azar (L. donovani) | Q2: Shigellosis (Shigella spp.) |
|---|
| Organism | Leishmania donovani | Shigella flexneri/dysenteriae |
| Vector/Route | Female sandfly | Fecal-oral |
| Pathogenesis | Intracellular survival in macrophages (RES) | Colonic invasion + T3SS + apoptosis induction |
| Key toxin | - | Shiga toxin (AB5) - inhibits protein synthesis |
| Diagnosis gold standard | Bone marrow/splenic aspirate Giemsa stain; rK39 ICT | Stool culture on MacConkey/XLD; NAATs/PCR |
| Key lab finding | LD bodies (amastigotes) in macrophages | NLF colonies + PMNs in stool |
| Serious complication | PKDL, severe pancytopenia | HUS, Toxic megacolon |
| Treatment | Sodium stibogluconate / Miltefosine | Fluoroquinolones / Azithromycin |